Is MTEM or BTI a better dividend investment in 2026?

MTEM currently yields 2000000.06% with a 5% 5-year dividend growth rate. BTI yields 5.38% with 5% growth. The better choice depends on your goal: MTEM offers higher current income.

What is the dividend yield difference between MTEM and BTI?

MTEM has a forward dividend yield of 2000000.06% ($2.00/share annually). BTI yields 5.38% ($3.15/share annually). The yield gap is 1999994.68 percentage points.

Home › Compare › MTEM vs BTI

MTEM vs BTI: Dividend Comparison 2026

MTEM yields 2000000.06% · BTI yields 5.38%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MTEM wins by $4.8792278646347776e+39M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MTEM

● Live price

2000000.06%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.8792278646347776e+39M

Annual income

$4,878,748,002,861,388,000,000,000,000,000,000,000,000,000,000.00

Full MTEM calculator →

BTI

● Live price

5.38%

Share price

$58.47

Annual div

$3.15

5Y div CAGR

11.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$37.7K

Annual income

$2,786.64

Full BTI calculator →

Portfolio growth — MTEM vs BTI

📍 MTEM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MTEM	BTI
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MTEM + BTI cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MTEM pays

BTI pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MTEM

Annual income on $10K today (after 15% tax)

$170,000,005.10/yr

After 10yr DRIP, annual income (after tax)

$4,146,935,802,432,179,400,000,000,000,000,000,000,000,000,000.00/yr

BTI

Annual income on $10K today (after 15% tax)

$457.40/yr

After 10yr DRIP, annual income (after tax)

$2,368.64/yr

At 15% tax rate, MTEM beats the other by $4,146,935,802,432,179,400,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MTEM + BTI for your $10,000?

MTEM: 50%BTI: 50%

100% BTI50/50100% MTEM

Portfolio after 10yr

$2.4396139323173888e+39M

Annual income

$2,439,374,001,430,694,000,000,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.99%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

MTEM

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Altman Z

-24.9

Piotroski

2/9

BTI

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$40.00

-31.6% upside vs current

Range: $40.00 — $40.00

Altman Z

2.1

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MTEM buys

BTI buys

No recent congressional trades found for MTEM or BTI in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMTEMBTI

Forward yield	2000000.06% ✓	5.38%
Annual dividend / share	$2.00	$3.15 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	11.3% ✓
Portfolio after 10y	$4.8792278646347776e+39M	$37.7K ✓
Annual income after 10y	$4,878,748,002,861,388,000,000,000,000,000,000,000,000,000,000.00 ✓	$2,786.64
Total dividends collected	$4.8791964691115763e+39M	$14.3K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Staples
Analyst consensus	Buy	Buy

Year-by-year: MTEM vs BTI ($10,000, DRIP)

Year	MTEM Portfolio	MTEM Income/yr	BTI Portfolio	BTI Income/yr	Gap
1← crossover	$200,010,706	$200,000,006.00	$11,299	$598.92	+$200.00M → MTEM
2	$3,738,731,992,770	$3,738,517,981,314.42	$12,794	$703.91	+$3738731.98M → MTEM
3	$65,315,068,744,949,500	$65,311,068,301,717,240.00	$14,518	$829.07	+$65315068744.93M → MTEM
4	$1,066,400,958,023,135,400,000	$1,066,331,070,899,578,300,000.00	$16,513	$978.64	+$1066400958023135.38M → MTEM
5	$16,272,185,237,131,282,000,000,000	$16,271,044,188,106,197,000,000,000.00	$18,827	$1,157.84	+$16272185237131282432.00M → MTEM
6	$232,054,281,880,765,440,000,000,000,000	$232,036,870,642,561,700,000,000,000,000.00	$21,518	$1,373.12	+$2.3205428188076545e+23M → MTEM
7	$3,092,799,715,549,616,000,000,000,000,000,000	$3,092,551,417,468,003,600,000,000,000,000,000.00	$24,657	$1,632.46	+$3.0927997155496157e+27M → MTEM
8	$38,524,114,942,504,994,000,000,000,000,000,000,000	$38,520,805,646,809,356,000,000,000,000,000,000,000.00	$28,329	$1,945.74	+$3.8524114942504996e+31M → MTEM
9	$448,468,947,092,778,960,000,000,000,000,000,000,000,000	$448,427,726,289,790,500,000,000,000,000,000,000,000,000.00	$32,637	$2,325.33	+$4.4846894709277894e+35M → MTEM
10	$4,879,227,864,634,777,500,000,000,000,000,000,000,000,000,000	$4,878,748,002,861,388,000,000,000,000,000,000,000,000,000,000.00	$37,708	$2,786.64	+$4.8792278646347776e+39M → MTEM

MTEM vs BTI: Complete Analysis 2026

MTEM — Stock

Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT-5111, an ETB candidate that is in Phase I clinical trial for the treatment of HER2-positive cancers; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory myeloma patients; and MT-6402 in that is in Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients. Its pipeline of ETBs in development for other targets, including CTLA-4, TIGIT, TROP2, BCMA, SLAMF-7, and CD45. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.

Full MTEM Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →

📬

Get this MTEM vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MTEM vs SCHD MTEM vs JEPI MTEM vs O MTEM vs KO MTEM vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.